Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment.

Autor: Zharinov GM; A.M. Granov Russian Research Center for Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation, Pesochny, St. Petersburg 197758, Russia., Bogomolov OA; A.M. Granov Russian Research Center for Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation, Pesochny, St. Petersburg 197758, Russia., Chepurnaya IV; A.M. Granov Russian Research Center for Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation, Pesochny, St. Petersburg 197758, Russia., Neklasova NY; A.M. Granov Russian Research Center for Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation, Pesochny, St. Petersburg 197758, Russia., Anisimov VN; N.N. Petrov National Medical Research Center of Oncology, Pesochny, St. Petersburg 197758, Russia.
Jazyk: angličtina
Zdroj: Oncotarget [Oncotarget] 2023 Feb 25; Vol. 14, pp. 149. Date of Electronic Publication: 2023 Feb 25.
DOI: 10.18632/oncotarget.28363
Databáze: MEDLINE